BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8666346)

  • 1. Hepatic mucosal mast cell hyperplasia in rats with secondary biliary cirrhosis.
    Rioux KP; Sharkey KA; Wallace JL; Swain MG
    Hepatology; 1996 Apr; 23(4):888-95. PubMed ID: 8666346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible role of mucosal mast cells in the recovery process of colitis induced by dextran sulfate sodium in rats.
    Iba Y; Sugimoto Y; Kamei C; Masukawa T
    Int Immunopharmacol; 2003 Apr; 3(4):485-91. PubMed ID: 12689654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased portal tract infiltration of mast cells and eosinophils in primary biliary cirrhosis.
    Nakamura A; Yamazaki K; Suzuki K; Sato S
    Am J Gastroenterol; 1997 Dec; 92(12):2245-9. PubMed ID: 9399763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The changes and significance of mast cells in irradiated rat liver.
    Peng RY; Wang DW; Xu ZH; Gao YB; Yang RB; Liu P; Wang ZP; Li YP
    J Environ Pathol Toxicol Oncol; 1994; 13(2):111-6. PubMed ID: 7884641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver impairment after portacaval shunt in the rat: the loss of protective role of mast cells?
    Aller MA; Martinez V; Corcuera MT; Benito J; Traver E; Gómez-Aguado F; Vergara P; Arias J
    Acta Histochem; 2012 Jul; 114(4):301-10. PubMed ID: 21937094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal platelet-activating factor synthesis during Nippostrongylus brasiliensis infection in the rat.
    Hogaboam CM; Befus AD; Wallace JL
    J Lipid Mediat; 1991; 4(2):211-24. PubMed ID: 1659465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mast cell chymase is a possible mediator of neurogenic bladder fibrosis.
    Howard PS; Renfrow D; Schechter NM; Kucich U
    Neurourol Urodyn; 2004; 23(4):374-82. PubMed ID: 15227657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase of mast cells in the liver and lung may be associated with but not a cause of fibrosis: demonstration using mast cell-deficient Ws/Ws rats.
    Okazaki T; Hirota S; Xu ZD; Maeyama K; Nakama A; Kawano S; Hori M; Kitamura Y
    Lab Invest; 1998 Nov; 78(11):1431-8. PubMed ID: 9840617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut mucosal mast cells in Nippostrongylus-primed rats are the major source of secreted rat mast cell protease II following systemic anaphylaxis.
    King SJ; Miller HR; Woodbury RG; Newlands GF
    Eur J Immunol; 1986 Feb; 16(2):151-5. PubMed ID: 3514235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tranilast reduces mesenteric vascular collagen deposition and chymase-positive mast cells in experimental diabetes.
    Jones SE; Gilbert RE; Kelly DJ
    J Diabetes Complications; 2004; 18(5):309-15. PubMed ID: 15337505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mast cell hyperplasia in chronic rejection after liver transplantation.
    O'Keeffe C; Baird AW; Nolan N; McCormick PA
    Liver Transpl; 2002 Jan; 8(1):50-7. PubMed ID: 11799486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mast cell stabilizer ketotifen [4-(1-methyl-4-piperidylidene)-4h-benzo[4,5]cyclohepta[1,2-b]thiophen-10(9H)-one fumarate] prevents mucosal mast cell hyperplasia and intestinal dysmotility in experimental Trichinella spiralis inflammation in the rat.
    Serna H; Porras M; Vergara P
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1104-11. PubMed ID: 16988056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stromal mast cells and nerve fibers in various chronic liver diseases: relevance to hepatic fibrosis.
    Matsunaga Y; Kawasaki H; Terada T
    Am J Gastroenterol; 1999 Jul; 94(7):1923-32. PubMed ID: 10406261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Morphopathological changes before and after biliodigestive derivation in experimental cirrhosis induced by biliary ligation in the rat].
    Marinelli Ibarreta A; Sánchez Movilla A; Izquierdo F; Burgos Lázaro F; Arce Alvarez A; del Castillo-Olivares Ramos JL
    Rev Esp Enferm Dig; 1995 Jan; 87(1):25-31. PubMed ID: 7727164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus-mediated inhibition of SPARC attenuates liver fibrosis in rats.
    Camino AM; Atorrasagasti C; Maccio D; Prada F; Salvatierra E; Rizzo M; Alaniz L; Aquino JB; Podhajcer OL; Silva M; Mazzolini G
    J Gene Med; 2008 Sep; 10(9):993-1004. PubMed ID: 18615449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes of mast cells and protease activated receptor-2 in experimental rat liver fibrosis].
    Xu KS; Li Q; Zhou X
    Zhonghua Gan Zang Bing Za Zhi; 2006 Oct; 14(10):753-6. PubMed ID: 17064469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic changes in hepatic mast cells accumulating around the metacestodes of Taenia taeniaeformis in rats.
    Ishiwata K; Oku Y; Kamiya M; Ohbayashi M
    APMIS; 1991 Feb; 99(2):179-86. PubMed ID: 1705806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relevance of mast cells and hepatic lobule innervation to liver injury.
    Stoyanova II
    Rom J Gastroenterol; 2004 Sep; 13(3):203-9. PubMed ID: 15470532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP Toxicology and Carcinogenesis Studies of 1,4-Dichlorobenzene (CAS No. 106-46-7) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1987 Jan; 319():1-198. PubMed ID: 12748734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of intrahepatic mast cells in various hepatobiliary disorders. An immunohistochemical study.
    Yamashiro M; Kouda W; Kono N; Tsuneyama K; Matsui O; Nakanuma Y
    Virchows Arch; 1998 Nov; 433(5):471-9. PubMed ID: 9849863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.